查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1637060

癌症營養療法的全球市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2032年)

Oncology Nutrition Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 186 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

受癌症發生率上升和專業營養支持需求的推動，全球癌症營養治療市場有望實現顯著增長。癌症營養治療市場規模預計2025年達到28.3億美元，複合年增長率為8.60%，預計到2032年將進一步擴大至50.4億美元。癌症治療的進步以及對營養在患者護理中的作用的日益認識使得這個市場走上了光明的道路。

腫瘤營養是醫療保健行業的一個專業，致力於滿足接受癌症治療的患者的獨特飲食需求。癌症治療常帶來營養不良、體重減輕和免疫系統減弱等課題。癌症營養治療旨在透過個人化的營養策略減輕這些影響，改善患者的生活品質並支持治療結果。

全球癌症發生率的上升凸顯了為患者提供量身定制的營養支持的必要性，以改善治療效果和控制治療相關的副作用。免疫療法和化學療法等治療方法的進步正在推動對補充營養策略的需求。營養配方的創新，包括有針對性的補充劑和免疫支持成分，擴大了癌症營養治療的範圍。醫療保健專業人員和患者越來越意識到營養對治療效果和整體健康的影響。

本報告提供全球癌症營養療法市場相關調查，提供市場概要，以及各癌症類型，各最終用途，及各地區趨勢，及市場參與市場企業的競爭趨勢等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場定義和市場區隔
  • 市場動態
  • 價值鏈分析
  • 波特的五力分析
  • COVID-19影響分析
  • 經濟概要
  • 大環境分析

第3章 全球癌症營養療法市場預測，2019年～2032年

  • 全球癌症營養療法市場預測，各癌症類型，金額(10億美元)，2019年～2032年
  • 全球癌症營養療法市場預測，各最終用途，金額(10億美元)，2019年～2032年
  • 全球癌症營養療法市場預測，各地區，金額(10億美元)，2019年～2032年

第4章 北美的癌症營養療法市場預測，2019年～2032年

第5章 歐洲的癌症營養療法市場預測，2019年～2032年

第6章 亞太地區的癌症營養療法市場預測，2019年～2032年

第7章 南美的癌症營養療法市場預測，2019年～2032年

第8章 中東·非洲的癌症營養療法市場預測，2019年～2032年

第9章 競爭情形

  • 企業市場佔有率分析，2025年
  • 競爭儀表板
  • 企業簡介
    • Aceto
    • B. Braun Melsungen AG
    • Baxter
    • Fresenius Kabi AG
    • Hormel Foods Corporation
    • Mead Johnson & Company, LLC
    • Meiji Holdings Co., Ltd
    • Nestle S.A.
    • BioSig Technologies, Inc.
    • Auris Health, Inc.
    • 其他

第10章 附錄

簡介目錄

The global oncology nutrition market is set to experience significant growth, driven by the increasing prevalence of cancer and the demand for specialized nutritional support. The oncology nutrition market is projected to reach a valuation of $2.83 billion in 2025 and expand further to $5.04 billion by 2032, at a CAGR of 8.60%. With advancements in cancer treatments and a heightened awareness of the role of nutrition in patient care, this market is on a promising trajectory.

Market Insights Oncology nutrition is a specialized segment of the healthcare industry dedicated to addressing the unique dietary needs of individuals undergoing cancer treatment. Cancer therapies often result in challenges such as malnutrition, weight loss, and weakened immune systems. Oncology nutrition aims to mitigate these effects through personalized nutritional strategies, improving patients' quality of life and supporting treatment outcomes.

Key Growth Drivers

  • 1. Rising Cancer Prevalence: The increasing global burden of cancer underscores the need for tailored nutritional support to enhance treatment outcomes and manage therapy-related side effects.
  • 2. Advancements in Cancer Treatments: Progress in therapies like immunotherapy and chemotherapy has elevated the demand for complementary nutritional strategies.
  • 3. Focus on Research and Development: Innovations in nutritional formulations, including targeted supplements and immune-supportive ingredients, have expanded the scope of oncology nutrition.
  • 4. Awareness of Nutrition's Role: Healthcare providers and patients are increasingly recognizing the impact of nutrition on treatment efficacy and overall well-being.

Business Opportunities

  • 1. Digital Health Solutions and Remote Monitoring: The integration of telehealth platforms and mobile applications presents opportunities for real-time nutritional support and patient monitoring, enhancing accessibility and convenience.
  • 2. Personalized Nutrition Products: The development of tailored supplements and meal replacements to address specific patient needs, such as difficulty swallowing or taste alterations, is driving innovation.
  • 3. Regional Expansion: Emerging markets in South Asia and the Pacific, with their increasing healthcare awareness and rising cancer burden, present significant growth opportunities.

Regional Analysis

  • 1. Europe: Europe leads the market with its robust healthcare infrastructure and emphasis on holistic cancer care, including nutritional support.
  • 2. South Asia and the Pacific: This region is the fastest-growing market, driven by an alarming rise in cancer cases and increasing healthcare awareness.
  • 3. North America: With advanced healthcare systems and a high prevalence of cancer, North America remains a significant contributor to the market.

Recent Developments

  • 1. Product Launch: In July 2022, Nestle introduced its first Foods for Special Medical Purposes (FSMP) for cancer patients in China, following a rigorous five-year regulatory approval process.
  • 2. Innovative Funding: In January 2022, Faeth Therapeutics secured $47 million in a Series A financing round to advance clinical trials integrating nutrient control, drugs, and digital tools for cancer management.

Key Players The competitive Analysis of the oncology nutrition market includes prominent players such as:

  • Aceto
  • B. Braun Melsungen AG
  • Baxter
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Mead Johnson & Company, LLC
  • Meiji Holdings Co., Ltd
  • Nestle S.A.
  • BioSig Technologies, Inc.
  • Auris Health, Inc.

Market Segmentation The oncology nutrition market is segmented as follows:

  • By Cancer Type: Head and Neck Cancers, Stomach and Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Esophageal Cancer, Lung Cancer, Breast Cancer, Blood Cancer, and Others.
  • By End-use: Hospitals & Clinics, Home Care, and Others.
  • By Region: North America, Europe, East Asia, South Asia & Oceania, Latin America, and the Middle East & Africa.

Table of Contents

1. Executive Summary

  • 1.1. Global Oncology Nutrition Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2025
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Economic Overview
    • 2.6.1. World Economic Projections
  • 2.7. PESTLE Analysis

3. Global Oncology Nutrition Market Outlook, 2019 - 2032

  • 3.1. Global Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Head and Neck Cancers
      • 3.1.1.2. Stomach and Gastrointestinal Cancers
      • 3.1.1.3. Liver Cancer
      • 3.1.1.4. Pancreatic Cancer
      • 3.1.1.5. Esophageal Cancer
      • 3.1.1.6. Lung Cancer
      • 3.1.1.7. Breast Cancer
      • 3.1.1.8. Blood Cancer
      • 3.1.1.9. Other Cancers
  • 3.2. Global Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals & Clinics
      • 3.2.1.2. Home Care
      • 3.2.1.3. Others
  • 3.3. Global Oncology Nutrition Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Oncology Nutrition Market Outlook, 2019 - 2032

  • 4.1. North America Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Head and Neck Cancers
      • 4.1.1.2. Stomach and Gastrointestinal Cancers
      • 4.1.1.3. Liver Cancer
      • 4.1.1.4. Pancreatic Cancer
      • 4.1.1.5. Esophageal Cancer
      • 4.1.1.6. Lung Cancer
      • 4.1.1.7. Breast Cancer
      • 4.1.1.8. Blood Cancer
      • 4.1.1.9. Other Cancers
  • 4.2. North America Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals & Clinics
      • 4.2.1.2. Home Care
      • 4.2.1.3. Others
  • 4.3. North America Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 4.3.1.2. Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 4.3.1.3. Canada Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 4.3.1.4. Canada Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Oncology Nutrition Market Outlook, 2019 - 2032

  • 5.1. Europe Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Head and Neck Cancers
      • 5.1.1.2. Stomach and Gastrointestinal Cancers
      • 5.1.1.3. Liver Cancer
      • 5.1.1.4. Pancreatic Cancer
      • 5.1.1.5. Esophageal Cancer
      • 5.1.1.6. Lung Cancer
      • 5.1.1.7. Breast Cancer
      • 5.1.1.8. Blood Cancer
      • 5.1.1.9. Other Cancers
  • 5.2. Europe Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals & Clinics
      • 5.2.1.2. Home Care
      • 5.2.1.3. Others
  • 5.3. Europe Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.2. Germany Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.3. U.K. Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.4. U.K. Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.5. France Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.6. France Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.7. Italy Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.8. Italy Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.9. Turkey Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.10. Turkey Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.11. Russia Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.12. Russia Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.13. Rest of Europe Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.14. Rest of Europe Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Oncology Nutrition Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Head and Neck Cancers
      • 6.1.1.2. Stomach and Gastrointestinal Cancers
      • 6.1.1.3. Liver Cancer
      • 6.1.1.4. Pancreatic Cancer
      • 6.1.1.5. Esophageal Cancer
      • 6.1.1.6. Lung Cancer
      • 6.1.1.7. Breast Cancer
      • 6.1.1.8. Blood Cancer
      • 6.1.1.9. Other Cancers
  • 6.2. Asia Pacific Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals & Clinics
      • 6.2.1.2. Home Care
      • 6.2.1.3. Others
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.2. China Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.3.1.3. Japan Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.4. Japan Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.3.1.5. South Korea Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.6. South Korea Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.3.1.7. India Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.8. India Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.3.1.9. Southeast Asia Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.10. Southeast Asia Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.3.1.11. Rest of Asia Pacific Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.12. Rest of Asia Pacific Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Oncology Nutrition Market Outlook, 2019 - 2032

  • 7.1. Latin America Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Head and Neck Cancers
      • 7.1.1.2. Stomach and Gastrointestinal Cancers
      • 7.1.1.3. Liver Cancer
      • 7.1.1.4. Pancreatic Cancer
      • 7.1.1.5. Esophageal Cancer
      • 7.1.1.6. Lung Cancer
      • 7.1.1.7. Breast Cancer
      • 7.1.1.8. Blood Cancer
      • 7.1.1.9. Other Cancers
  • 7.2. Latin America Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
      • 7.2.1.1. Hospitals & Clinics
      • 7.2.1.2. Home Care
      • 7.2.1.3. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.2. Brazil Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.3.1.3. Mexico Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.4. Mexico Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.3.1.5. Argentina Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.6. Argentina Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.3.1.7. Rest of Latin America Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.8. Rest of Latin America Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Oncology Nutrition Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Head and Neck Cancers
      • 8.1.1.2. Stomach and Gastrointestinal Cancers
      • 8.1.1.3. Liver Cancer
      • 8.1.1.4. Pancreatic Cancer
      • 8.1.1.5. Esophageal Cancer
      • 8.1.1.6. Lung Cancer
      • 8.1.1.7. Breast Cancer
      • 8.1.1.8. Blood Cancer
      • 8.1.1.9. Other Cancers
  • 8.2. Middle East & Africa Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals & Clinics
      • 8.2.1.2. Home Care
      • 8.2.1.3. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.2. GCC Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.3.1.3. South Africa Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.4. South Africa Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.3.1.5. Egypt Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.6. Egypt Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.3.1.7. Nigeria Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.8. Nigeria Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.3.1.9. Rest of Middle East & Africa Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.10. Rest of Middle East & Africa Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2025
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. Aceto
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Therapy Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. B. Braun Melsungen AG
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Therapy Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. Baxter
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Therapy Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. Fresenius Kabi AG
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Therapy Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. Hormel Foods Corporation
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Therapy Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. Mead Johnson & Company, LLC
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Therapy Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. Meiji Holdings Co., Ltd
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Therapy Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. Nestle S.A.
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Therapy Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. BioSig Technologies, Inc.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Therapy Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development
    • 9.3.10. Auris Health, Inc.
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Therapy Portfolio
      • 9.3.10.3. Financial Overview
      • 9.3.10.4. Business Strategies and Development
    • 9.3.11. Others
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Therapy Portfolio
      • 9.3.11.3. Financial Overview
      • 9.3.11.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations